EquityFlowCompanies › Vivalyx

Vivalyx

biotech · Aachen, DE

Develops technology to revitalise donor organs via organ preservation fluid.

Funding history

DateRoundAmount
Apr 2024Funding round
Aachen life-science startup Vivalyx raised 5 million euros for its donor-organ preservation technology.
$5.2M
Jun 2023Seed
Aachen life-science startup Vivalyx raised an undisclosed seven-figure sum from transplantation experts, an angel fund and footballer Mario Goetze.

Investors

Arve CapitalBrightlands Venture PartnersMario GoetzeTechVision Fonds

Similar companies in biotech

Explore funding flow on EquityFlow →